24 June, 2017
Yorktown Management And Rech Company invested in 0.07% or 700 shares. Following the completion of the sale, the director now directly owns 3,000 shares of the company's stock, valued at $1,500,000. Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has risen 17.40% since June 23, 2016 and is uptrending. It has outperformed by 0.70% the S&P500. 0 funds opened positions while 8 raised stakes. The current share price indicate that stock is -4.01% away from its one year high and is moving 47.23% ahead of its 52-week low. CNH Industrial NV (NYSE:CNHI) has risen 66.12% since June 23, 2016 and is uptrending. It has underperformed by 16.70% the S&P500.
Many investors are putting up stocks for sale that now have some strength but are expected to reverse in price. Its up 0.29, from 0.96 in 2016Q3. It increased, as 48 investors sold REGN shares while 151 reduced holdings. The stock decreased 0.87% or $0.1 during the last trading session, reaching $11.44. Blackrock Institutional Trust Company Na holds 0% or 25,438 shares. The stock of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has "Hold" rating given on Wednesday, January 27 by Canaccord Genuity. New England & holds 0.21% or 730 shares. Northern Corporation reported 894,822 shares. On Wednesday, January 11 Sanofi bought $32.27 million worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) or 87,298 shares. Finally, Zacks Investment Research upgraded shares of Regeneron Pharmaceuticals from a "hold" rating to a "buy" rating and set a $416.00 target price for the company in a report on Thursday, April 27th. Raymond James Na owns 758 shares. John G Ullman Assocs has invested 0.07% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Nicholas Company Inc. maintained its stake in Regeneron Pharmaceuticals, Inc. Bennicas owns 1,950 shares. The shares are at this time trading 0.41% more than its SMA 50 and 5.90% top of its SMA 200. Geneva Ltd Liability Com owns 6,670 shares for 0.05% of their portfolio. Reliance Trust Of Delaware reported 1,974 shares or 0.11% of all its holdings.
Regeneron Pharmaceuticals, Inc.'s P/E stands at 62.8, while the P/S is at 11.38 and earnings per share this year of 39.50%. On average, equities analysts anticipate that Regeneron Pharmaceuticals, Inc. will post $12.67 EPS for the current year. Everpoint Asset Management Ltd Liability Company reported 0.03% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Therefore 9% are positive.
A number of equities analysts have recently issued reports on REGN shares. Leerink Swann has "Outperform" rating and $630 target. Jgp Global Gestao De Recursos Ltda acquired 828 shares as Regeneron Pharmaceuticals (REGN)'s stock rose 21.24%. The stock has "Neutral" rating by Piper Jaffray on Monday, November 28. BMO Capital Markets reaffirmed a "market perform" rating and issued a $421.00 price target on shares of Regeneron Pharmaceuticals in a research note on Wednesday.
05/05/2017 - Regeneron Pharmaceuticals, Inc. had its "buy" rating reiterated by analysts at UBS. They now have a Dollars 460 price target on the stock.
02/10/2017 - Regeneron Pharmaceuticals, Inc. had its "buy" rating reiterated by analysts at Citigroup. PEG ratio for Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is 3.28.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN)'s quick ratio for most recent quarter is 2.60. "Makes Most of Its Money" published on May 31, 2017, Seekingalpha.com published: "Put Regeneron On Your Investment Radar In 2017" on June 21, 2017.
05/05/2017 - Regeneron Pharmaceuticals, Inc. had its "equal weight" rating reiterated by analysts at Barclays.
Investors sentiment decreased to 1.33 in Q4 2016. Its up 0.20, from 1 in 2016Q3. 60 funds opened positions while 188 raised stakes. Suntrust Banks reported 3,146 shares stake. Of Vermont holds 24 shares. Voya Inv Ltd Limited Liability Company owns 53,889 shares. Salient Cap Llc holds 0.01% or 1,350 shares in its portfolio. Franklin Res Inc owns 1.38 million shares. Envestnet Asset Mgmt Inc invested in 0.02% or 15,974 shares. Corporate insiders own 10.40% of the company's stock. Tci Wealth Advsrs owns 163 shares for 0% of their portfolio.
02/16/2017 - Regeneron Pharmaceuticals, Inc. was downgraded to "neutral" by analysts at Goldman Sachs. The firm has "Buy" rating given on Tuesday, January 19 by Roth Capital. The company was downgraded on Wednesday, July 29 by Bank of America. Brean Capital reinitiated the stock with "Buy" rating in Tuesday, March 8 report. The rating was maintained by Bank of America with "Buy" on Thursday, June 9.
CNH Industrial N.V.is a capital goods company. On Friday, December 4 the stock rating was initiated by Wells Fargo with "Outperform".
Pinnacle Associates Ltd, which manages about $6.31 billion and $4.96 billion US Long portfolio, upped its stake in Dow Chem Co (NYSE:DOW) by 6,279 shares to 121,723 shares, valued at $6.97M in 2016Q4, according to the filing. L P increased its stake in Regeneron Pharmaceuticals by 49.4% in the fourth quarter.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.